搜尋
Vir Biotechnology Inc
VIR添加自選
8.660USD
-0.240-2.70%
收盤 07-31 16:00（美東）報價延遲15分鐘
1.46B總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
8.35%
SB Investment Advisers (UK) Limited
7.78%
ARCH Venture Partners
7.66%
Vanguard Portfolio Management, LLC
5.46%
GSK plc
5.07%
其他
65.68%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
8.35%
SB Investment Advisers (UK) Limited
7.78%
ARCH Venture Partners
7.66%
Vanguard Portfolio Management, LLC
5.46%
GSK plc
5.07%
其他
65.68%
股東類型
持股股東
佔比
Investment Advisor
27.80%
Investment Advisor/Hedge Fund
14.04%
Private Equity
9.19%
Venture Capital
8.00%
Hedge Fund
5.85%
Corporation
5.07%
Research Firm
3.25%
Individual Investor
1.50%
Foundation
0.92%
其他
24.39%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
497
130.35M
77.29%
+9.59M
2025Q4
484
108.68M
78.12%
-13.10M
2025Q3
481
113.05M
81.28%
-6.82M
2025Q2
530
124.85M
89.88%
-15.28M
2025Q1
571
125.80M
91.30%
-16.44M
2024Q4
568
122.14M
89.06%
-13.83M
2024Q3
554
118.76M
86.83%
-17.44M
2024Q2
572
119.53M
87.47%
-20.55M
2024Q1
564
122.68M
91.07%
-16.10M
2023Q4
577
121.87M
90.75%
-16.40M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
14.08M
8.81%
+357.12K
+2.60%
Dec 31, 2025
SB Investment Advisers (UK) Limited
13.12M
8.21%
-1.34M
-9.28%
Dec 31, 2025
ARCH Venture Partners
12.92M
8.08%
--
--
Feb 27, 2026
GSK plc
8.55M
5.35%
--
--
Dec 31, 2025
State Street Investment Management (US)
6.23M
3.9%
+988.26K
+18.86%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.54M
1.59%
-442.59K
-14.86%
Dec 31, 2025
OrbiMed Advisors, LLC
2.38M
1.49%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.33M
1.46%
+81.98K
+3.65%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Genomics Immunology and Healthcare ETF
1.13%
Virtus LifeSci Biotech Clinical Trials ETF
0.77%
Invesco NASDAQ Future Gen 200 ETF
0.65%
Global X Genomics & Biotechnology ETF
0.59%
Invesco S&P SmallCap Health Care ETF
0.34%
ALPS Medical Breakthroughs ETF
0.34%
Hypatia Women CEO ETF
0.27%
State Street SPDR S&P Biotech ETF
0.2%
ProShares Ultra Nasdaq Biotechnology
0.11%
Direxion Daily S&P Biotech Bull 3X Shares
0.1%
查看更多
iShares Genomics Immunology and Healthcare ETF
佔比1.13%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.77%
Invesco NASDAQ Future Gen 200 ETF
佔比0.65%
Global X Genomics & Biotechnology ETF
佔比0.59%
Invesco S&P SmallCap Health Care ETF
佔比0.34%
ALPS Medical Breakthroughs ETF
佔比0.34%
Hypatia Women CEO ETF
佔比0.27%
State Street SPDR S&P Biotech ETF
佔比0.2%
ProShares Ultra Nasdaq Biotechnology
佔比0.11%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.1%